BioCentury
ARTICLE | Clinical News

CGX-1160 regulatory update

September 5, 2005 7:00 AM UTC

FDA granted Orphan Drug designation to CGX-1160 for the intrathecal treatment of neuropathic pain associated with spinal cord injury. The broad spectrum non-opioid analgesic has completed a Phase Ib t...